Biomarkers of multimorbidity: A systematic review
Open Access
- 13 August 2025
- journal article
- review article
- Published by Elsevier in Ageing Research Reviews
- Vol. 112, 102870
Abstract
No abstract availableKeywords
Funding Information
- European Commission
- Vetenskapsrådet (2021\u201303324)
This publication has 108 references indexed in Scilit:
- Blood biomarkers of Alzheimer's disease in the community: Variation by chronic diseases and inflammatory statusAlzheimer's & Dementia, 2024
- Assessment of six surrogate insulin resistance indexes for predicting cardiometabolic multimorbidity incidence in Chinese middle‐aged and older populations: Insights from the China health and retirement longitudinal studyDiabetes/Metabolism Research and Reviews, 2024
- Multimorbidity, cognitive phenotypes, and Alzheimer's disease plasma biomarkers in older adults: A population‐based studyAlzheimer's & Dementia, 2023
- Elevated AST/ALT ratio is associated with all‐cause mortality and cancer incidentJournal of Clinical Laboratory Analysis, 2022
- Associations of amyloid and neurodegeneration plasma biomarkers with comorbiditiesAlzheimer's & Dementia, 2021
- Serum cystatin C as a predictor of 90‐day mortality among patients admitted with complications of cirrhosisJGH Open, 2021
- Association of Homocysteine, Methionine, and MTHFR 677C>T Polymorphism With Rate of Cardiovascular Multimorbidity Development in Older Adults in SwedenJAMA Network Open, 2020
- Fibronectin splice variants: Understanding their multiple roles in health and disease using engineered mouse modelsIUBMB Life, 2011
- Red Blood Cell Distribution Width and the Risk of Death in Middle-aged and Older AdultsArchives of internal medicine (1960), 2009
- Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and WomenJAMA, 2007